Old Web
English
Sign In
Acemap
>
Paper
>
Inhibiting The xCT Antiporter Sensitizes High Risk DLBCL to Doxorubicin-Containing Therapy
Inhibiting The xCT Antiporter Sensitizes High Risk DLBCL to Doxorubicin-Containing Therapy
2021
Xiaolei Wei
Yongqiang Wei
Jialin Song
Yun Mai
Fei Yuan
Jinghang Zhang
Ru Feng
Bihui Hilda Ye
Keywords:
Antiporter
Doxorubicin
Cancer research
Chemistry
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]